Brief: Piramal Pharma Solutions Achieves Regulatory Compliance For Nitrosamine Impurities
26/11/2025 20:02
Nov 26 (Reuters) - Piramal Pharma Ltd PIRM.NS: PIRAMAL PHARMA SOLUTIONS ACHIEVES REGULATORY COMPLIANCE FOR NITROSAMINE IMPURITIES Source text: ID:nPn41sscqa Further company coverage: PIRM.NS
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington